RT Journal Article
SR Electronic
T1 Analysis of antibody data using Finite Mixture Models based on Scale Mixtures of Skew-Normal distributions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.08.21252807
DO 10.1101/2021.03.08.21252807
A1 Tiago Dias Domingues
A1 Helena Mouriño
A1 Nuno Sepúlveda
YR 2021
UL http://medrxiv.org/content/early/2021/03/09/2021.03.08.21252807.abstract
AB Finite mixture models have been widely used in antibody (or serological) data analysis in order to help classifying individuals into either antibody-positive or antibody-negative. The most popular models are the so-called Gaussian mixture models which assume a Normal distribution for each component of a mixture. In this work, we propose the use of finite mixture models based on a flexible class of scale mixtures of Skew-Normal distributions for serological data analysis. These distributions are sufficiently flexible to describe right and left asymmetry often observed in the distributions associated with hypothetical antibody-negative and antibody-positive individuals, respectively. We illustrate the advantage of these alternative mixture models with a data set of 406 individuals in which antibodies against six different human herpesviruses were measured in the context of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially funded by Fundação para a Ciência e a Tecnologia, Portugal (ref:UIDB/00006/2020 and UIDB/04561/2020) and resulted from a short-term scientific mission of TDS to the LSHTM funded by the EUROMENE Cost Action (CA15111) from the European UnionAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided written informed consent for data collection (questionnaire, clinical measurement and laboratory tests), and for allowing their samples to be available to any research receiving ethical approval. Participants received an extensive information sheet and consent form in which there was an option for participation withdraw from the study at any time. Ethical approval was granted by the London School of Hygiene and Tropical Medicine (LSHTM) Ethics Committee (Ref. 6123) and the National Research Ethics Service (NRES) London-Bloomsbury Research Ethics Committee (REC ref. 11/10/1760, IRAS ID: 77765).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data under analysis is part of a database dedicated to Chronic Fatigue, and is the responsibility of the London School of Hygiene and Tropical Medicine working group